Related Experiment Video

Updated: Mar 16, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

662

Fibrosis Progression in Patients With Chronic Hepatitis C Virus Infection

Marija Zeremski1, Rositsa B Dimova2, Jaroslaw Pillardy3

  • 1Division of Gastroenterology and Hepatology, Weill Cornell Medical College.

The Journal of Infectious Diseases
|August 4, 2016
PubMed

Insights

Fibrosis progression in hepatitis C virus (HCV) infection varies by stage, with faster advancement in early stages. Patients experiencing alanine aminotransferase (ALT) flares show increased fibrosis progression.

Area of Science:

  • Hepatology
  • Virology
  • Medical Statistics

Background:

  • Hepatitis C virus (HCV) infection is a leading cause of chronic liver disease.
  • Fibrosis progression in HCV varies significantly among individuals.
  • Understanding factors influencing fibrosis progression is crucial for patient management.

Purpose of the Study:

  • To investigate factors influencing fibrosis progression in chronic HCV infection.
  • To analyze the relationship between fibrosis stage, alanine aminotransferase (ALT) flares, and disease progression.
  • To identify specific HCV genotypes associated with increased cirrhosis risk.

Main Methods:

  • Retrospective analysis of 936 liver biopsy specimens from 378 HCV-infected patients.
  • Logistic regression and multistate Markov modeling used to analyze associations.
  • Inclusion criteria: at least two liver biopsies per patient.

Main Results:

  • Fibrosis progression was associated with lower initial fibrosis (P < .001) and occurrence of ALT flares (P = .007).
  • Highest progression rates observed between fibrosis stages 0 and 1; lowest between stages 2 and 3.
  • HCV genotype 3 infection was linked to a higher likelihood of progressing to cirrhosis (P < .001).

Conclusions:

  • HCV fibrosis progression is non-linear and stage-dependent.
  • Early-stage fibrosis and ALT flares are indicators of accelerated disease progression.
  • HCV genotype 3 poses a greater risk for cirrhosis development.
Abstract

Keywords:
alanine aminotransferasecirrhosisliver biopsyliver disease progressionviral hepatitis

More Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.3K
Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration10:42

Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration

Published on: May 13, 2016

9.6K

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
313
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
846
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
998
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.0K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
248
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
457